BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 31704226)

  • 1. Evaluation of two commercially available chikungunya virus IgM enzyme-linked immunoassays (ELISA) in a setting of concomitant transmission of chikungunya, dengue and Zika viruses.
    Kikuti M; Tauro LB; Moreira PSS; Nascimento LCJ; Portilho MM; Soares GC; Weaver SC; Reis MG; Kitron U; Ribeiro GS
    Int J Infect Dis; 2020 Feb; 91():38-43. PubMed ID: 31704226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela.
    Morales I; Rosenberger KD; Magalhaes T; Morais CNL; Braga C; Marques ETA; Calvet GA; Damasceno L; Brasil P; Bispo de Filippis AM; Tami A; Bethencourt S; Alvarez M; Martínez PA; Guzman MG; Souza Benevides B; Caprara A; Quyen NTH; Simmons CP; Wills B; de Lamballerie X; Drexler JF; Jaenisch T;
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009336. PubMed ID: 33872309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zika virus displacement by a chikungunya outbreak in Recife, Brazil.
    Magalhaes T; Braga C; Cordeiro MT; Oliveira ALS; Castanha PMS; Maciel APR; Amancio NML; Gouveia PN; Peixoto-da-Silva VJ; Peixoto TFL; Britto H; Lima PV; Lima ARS; Rosenberger KD; Jaenisch T; Marques ETA
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006055. PubMed ID: 29108009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of serological tests for the diagnosis of Chikungunya virus infection: A systematic review and meta-analysis.
    Andrew A; Navien TN; Yeoh TS; Citartan M; Mangantig E; Sum MSH; Ch'ng ES; Tang TH
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010152. PubMed ID: 35120141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Transmission of Dengue, Chikungunya, and Zika Viruses in Brazil: Clinical and Epidemiological Findings From Surveillance for Acute Febrile Illness.
    Silva MMO; Tauro LB; Kikuti M; Anjos RO; Santos VC; Gonçalves TSF; Paploski IAD; Moreira PSS; Nascimento LCJ; Campos GS; Ko AI; Weaver SC; Reis MG; Kitron U; Ribeiro GS
    Clin Infect Dis; 2019 Sep; 69(8):1353-1359. PubMed ID: 30561554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil.
    Mota ML; Dos Santos Souza Marinho R; Duro RLS; Hunter J; de Menezes IRA; de Lima Silva JMF; Pereira GLT; Sabino EC; Grumach A; Diaz RS; do Socorro Lucena M; Komninakis SV
    BMC Infect Dis; 2021 Jul; 21(1):704. PubMed ID: 34303348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.
    Prince HE; Altrich ML; Nowicki MJ
    Clin Vaccine Immunol; 2016 Oct; 23(10):825-830. PubMed ID: 27535838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection.
    Kikuti M; Tauro LB; Moreira PSS; Campos GS; Paploski IAD; Weaver SC; Reis MG; Kitron U; Ribeiro GS
    Virol J; 2018 Jul; 15(1):108. PubMed ID: 30005683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue and Chikungunya Virus Co-infections: The Inside Story.
    Londhey V; Agrawal S; Vaidya N; Kini S; Shastri JS; Sunil S
    J Assoc Physicians India; 2016 Mar; 64(3):36-40. PubMed ID: 27731556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: a population-based seroprevalence study in Brazil.
    Barreto FKA; Alencar CH; Araújo FMC; Oliveira RMAB; Cavalcante JW; Lemos DRQ; Farias LABG; Boriz ILF; Medeiros LQ; Melo MNP; Miyajima F; Siqueira AM; Freitas ARR; Cavalcanti LPG
    BMC Infect Dis; 2020 Nov; 20(1):881. PubMed ID: 33234110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and serological techniques to detect co-circulation of DENV, ZIKV and CHIKV in suspected dengue-like syndrome patients.
    Cabral-Castro MJ; Cavalcanti MG; Peralta RHS; Peralta JM
    J Clin Virol; 2016 Sep; 82():108-111. PubMed ID: 27479173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
    Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
    PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-circulation and simultaneous co-infection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border.
    Carrillo-Hernández MY; Ruiz-Saenz J; Villamizar LJ; Gómez-Rangel SY; Martínez-Gutierrez M
    BMC Infect Dis; 2018 Jan; 18(1):61. PubMed ID: 29382300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluation of an in-House IgM-Capture ELISA for the Detection of Chikungunya and Its Application to a Dengue Outbreak Situation in Kenya in 2013.
    Wasonga C; Inoue S; Kimotho J; Morita K; Ongus J; Sang R; Musila L
    Jpn J Infect Dis; 2015; 68(5):410-4. PubMed ID: 25866119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of Chikungunya virus circulation in the Terai region of Nepal in 2014 and 2015.
    Pandey K; Pandey BD; Chaurasiya RR; Thakur M; Neupane B; Shah Y; Ngwe Tun MM; Morita K
    Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):294-299. PubMed ID: 29165625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays.
    Johnson BW; Goodman CH; Holloway K; de Salazar PM; Valadere AM; Drebot MA
    Am J Trop Med Hyg; 2016 Jul; 95(1):182-192. PubMed ID: 26976887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical presentation and out-comes of Chikungunya and Dengue virus infections in patients with acute undifferentiated febrile illness from the Sindh region of Pakistan.
    Shahid U; Farooqi JQ; Barr KL; Mahmood SF; Jamil B; Imitaz K; Azizullah Z; Malik FR; Prakoso D; Long MT; Khan E
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008086. PubMed ID: 32203509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India.
    Afreen N; Deeba F; Khan WH; Haider SH; Kazim SN; Ishrat R; Naqvi IH; Shareef MY; Broor S; Ahmed A; Parveen S
    Microbiol Immunol; 2014 Dec; 58(12):688-96. PubMed ID: 25346397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an immunochromatography rapid diagnosis kit for detection of chikungunya virus antigen in India, a dengue-endemic country.
    Jain J; Okabayashi T; Kaur N; Nakayama E; Shioda T; Gaind R; Kurosu T; Sunil S
    Virol J; 2018 May; 15(1):84. PubMed ID: 29751761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
    Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.